ALISHA HALL: Open Payments
NPI 1922424548 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 40 payments from 12 companies in 2025. Trend: 2023 $246 · 2024 $510 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $173 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Novo Nordisk Inc | 5 | $101 |
| Lilly USA, LLC | 4 | $85 |
| PFIZER INC. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Exact Sciences Corporation | 2 | $37 |
| Bioventus LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, AIRSUPRA, MOUNJARO, REXULTI, Wegovy, Cologuard Collection Kit, SHINGRIX, ELIQUIS.
Industry payments across MI — which companies pay providers there.
